tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:HIK Stock Latest News

Hikma launches $250m buyback with first £1.2m share purchase
Company AnnouncementsHikma launches $250m buyback with first £1.2m share purchase
13h ago
Hikma Pharmaceuticals Balances Profit Strength With Injectables Reset
PremiumCompany Announcements
Hikma Pharmaceuticals Balances Profit Strength With Injectables Reset
20h ago
Hikma launches $250m share buyback to bolster capital efficiency and signal growth confidence
PremiumCompany Announcements
Hikma launches $250m share buyback to bolster capital efficiency and signal growth confidence
2d ago
Hikma posts revenue growth, launches $250m buyback and overhauls leadership
PremiumCompany Announcements
Hikma posts revenue growth, launches $250m buyback and overhauls leadership
2d ago
Hikma Sets Date for 2025 Full-Year Results Announcement
PremiumCompany Announcements
Hikma Sets Date for 2025 Full-Year Results Announcement
25d ago
Hikma Pharmaceuticals downgraded to Underweight at Barclays amid uncertainty
PremiumThe FlyHikma Pharmaceuticals downgraded to Underweight at Barclays amid uncertainty
2M ago
Hikma Pharmaceuticals downgraded to Underweight from Equal Weight at Barclays
Premium
The Fly
Hikma Pharmaceuticals downgraded to Underweight from Equal Weight at Barclays
2M ago
Hikma Executive Vice Chairman Buys £1.5m of Company Shares
Premium
Company Announcements
Hikma Executive Vice Chairman Buys £1.5m of Company Shares
2M ago
Hikma directors restructure pledges over 2.5 million shares via Darhold Limited
PremiumCompany Announcements
Hikma directors restructure pledges over 2.5 million shares via Darhold Limited
2M ago
Hikma Pharmaceuticals Announces Share Pledge Transactions by Key Executives
PremiumCompany Announcements
Hikma Pharmaceuticals Announces Share Pledge Transactions by Key Executives
2M ago
Hikma Pharmaceuticals Announces Leadership Changes and Board Appointment
PremiumCompany Announcements
Hikma Pharmaceuticals Announces Leadership Changes and Board Appointment
2M ago
Hikma Pharmaceuticals Chairman Acquires Significant Shareholding
PremiumCompany Announcements
Hikma Pharmaceuticals Chairman Acquires Significant Shareholding
4M ago
Hikma Pharmaceuticals Executives Increase Shareholdings
PremiumCompany AnnouncementsHikma Pharmaceuticals Executives Increase Shareholdings
4M ago
Hikma Pharmaceuticals Updates 2025 Guidance and Medium-Term Outlook
Premium
Company Announcements
Hikma Pharmaceuticals Updates 2025 Guidance and Medium-Term Outlook
4M ago
Hikma Pharmaceuticals Executives Acquire Shares, Signaling Confidence
Premium
Company Announcements
Hikma Pharmaceuticals Executives Acquire Shares, Signaling Confidence
5M ago
Hikma Pharmaceuticals Executive Vice Chairman Acquires Shares
PremiumCompany Announcements
Hikma Pharmaceuticals Executive Vice Chairman Acquires Shares
5M ago
Hikma Pharmaceuticals Director Acquires Shares, Signaling Confidence
PremiumCompany Announcements
Hikma Pharmaceuticals Director Acquires Shares, Signaling Confidence
6M ago
Hikma Pharmaceuticals Executive Exercises Share Options
PremiumCompany Announcements
Hikma Pharmaceuticals Executive Exercises Share Options
7M ago
Hikma Pharmaceuticals’ Earnings Call: Mixed Financial Performance
PremiumCompany Announcements
Hikma Pharmaceuticals’ Earnings Call: Mixed Financial Performance
7M ago
Hikma Pharmaceuticals Executive Vice Chairman Acquires Significant Shareholding
PremiumCompany AnnouncementsHikma Pharmaceuticals Executive Vice Chairman Acquires Significant Shareholding
7M ago
Hikma Pharmaceuticals Reports Strong H1 2025 Performance and Positive Outlook
Premium
Company Announcements
Hikma Pharmaceuticals Reports Strong H1 2025 Performance and Positive Outlook
7M ago
Hikma Pharmaceuticals Issues $500 Million in Guaranteed Notes
Premium
Company Announcements
Hikma Pharmaceuticals Issues $500 Million in Guaranteed Notes
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >